ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001532218

Patel Sanj K

CIK 0001532218 Name as filed on the most recent filing

Filed as Patel Sanj K (28)

87 transaction lines · from 28 filings · filed 2012-03-27 to 2026-05-01 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

87 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2014-01-28 Synageva Biopharma Corp
GEVA 		S, Open-market sale 8,402 disposed 88.95 747,357.90 Form 4, filing 0001246360-14-000472
2014-01-28 Synageva Biopharma Corp
GEVA 		S, Open-market sale 812 disposed 90.10 73,161.20 Form 4, filing 0001246360-14-000472
2013-07-29 Synageva Biopharma Corp
GEVA 		S, Open-market sale 15,895 disposed 47.39 753,264.05 Form 4, filing 0001246360-13-003708
2013-07-26 Synageva Biopharma Corp
GEVA 		S, Open-market sale 52,190 disposed 47.91 2,500,422.90 Form 4, filing 0001246360-13-003708
2013-07-26 Synageva Biopharma Corp
GEVA 		S, Open-market sale 17,204 disposed 48.31 831,125.24 Form 4, filing 0001246360-13-003708
2013-07-25 Synageva Biopharma Corp
GEVA 		S, Open-market sale 14,711 disposed 48.73 716,867.03 Form 4, filing 0001246360-13-003708
2013-06-12 Synageva Biopharma Corp
GEVA 		S, Open-market sale 40,352 disposed 40.48 1,633,448.96 Form 4, filing 0001246360-13-003314
2013-06-11 Synageva Biopharma Corp
GEVA 		S, Open-market sale 29,648 disposed 40.89 1,212,306.72 Form 4, filing 0001246360-13-003314
2013-04-08 Synageva Biopharma Corp
GEVA 		S, Open-market sale 21,695 disposed 49.49 1,073,685.55 Form 4, filing 0001246360-13-002419
2013-04-05 Synageva Biopharma Corp
GEVA 		S, Open-market sale 9,910 disposed 50.11 496,590.10 Form 4, filing 0001246360-13-002419
2013-04-04 Synageva Biopharma Corp
GEVA 		S, Open-market sale 18,580 disposed 50.12 931,248.18 Form 4, filing 0001246360-13-002414
2013-04-04 Synageva Biopharma Corp
GEVA 		S, Open-market sale 2,151 disposed 50.72 109,098.72 Form 4, filing 0001246360-13-002414
2013-04-04 Synageva Biopharma Corp
GEVA 		S, Open-market sale 1,200 disposed 51.64 61,968.00 Form 4, filing 0001246360-13-002414
2013-04-03 Synageva Biopharma Corp
GEVA 		S, Open-market sale 10,206 disposed 51.08 521,373.51 Form 4, filing 0001246360-13-002414
2013-04-03 Synageva Biopharma Corp
GEVA 		S, Open-market sale 4,358 disposed 52.55 229,017.26 Form 4, filing 0001246360-13-002414
2013-04-03 Synageva Biopharma Corp
GEVA 		S, Open-market sale 1,500 disposed 53.37 80,059.50 Form 4, filing 0001246360-13-002414
2013-04-03 Synageva Biopharma Corp
GEVA 		S, Open-market sale 400 disposed 54.44 21,777.20 Form 4, filing 0001246360-13-002414
2013-02-21 Synageva Biopharma Corp
GEVA 		S, Open-market sale 45,392 disposed 49.02 2,225,115.84 Form 4, filing 0001246360-13-001561
2013-02-20 Synageva Biopharma Corp
GEVA 		S, Open-market sale 18,654 disposed 49.49 923,186.46 Form 4, filing 0001246360-13-001561
2013-02-20 Synageva Biopharma Corp
GEVA 		S, Open-market sale 5,954 disposed 49.60 295,318.40 Form 4, filing 0001246360-13-001561
2012-12-17 Synageva Biopharma Corp
GEVA 		S, Open-market sale 23,715 disposed 47.03 1,115,316.45 Form 4, filing 0001246360-12-004891
2012-12-17 Synageva Biopharma Corp
GEVA 		S, Open-market sale 7,004 disposed 45.97 321,973.88 Form 4, filing 0001246360-12-004891
2012-12-17 Synageva Biopharma Corp
GEVA 		S, Open-market sale 1,600 disposed 47.53 76,048.00 Form 4, filing 0001246360-12-004891
2012-12-14 Synageva Biopharma Corp
GEVA 		S, Open-market sale 13,281 disposed 45.30 601,629.30 Form 4, filing 0001246360-12-004891
2012-12-13 Synageva Biopharma Corp
GEVA 		S, Open-market sale 8,399 disposed 45.12 378,962.88 Form 4, filing 0001246360-12-004891
2012-12-13 Synageva Biopharma Corp
GEVA 		S, Open-market sale 3,300 disposed 45.87 151,371.00 Form 4, filing 0001246360-12-004891
2012-12-13 Synageva Biopharma Corp
GEVA 		S, Open-market sale 2,701 disposed 47.07 127,136.07 Form 4, filing 0001246360-12-004891
2012-12-05 Synageva Biopharma Corp
GEVA 		S, Open-market sale 12,000 disposed 48.10 577,255.20 Form 4, filing 0001246360-12-004640
2012-12-04 Synageva Biopharma Corp
GEVA 		S, Open-market sale 23,000 disposed 49.34 1,134,849.90 Form 4, filing 0001246360-12-004640
2012-12-03 Synageva Biopharma Corp
GEVA 		S, Open-market sale 30,000 disposed 49.42 1,482,492.00 Form 4, filing 0001246360-12-004606
2012-11-30 Synageva Biopharma Corp
GEVA 		S, Open-market sale 5,000 disposed 48.87 244,326.00 Form 4, filing 0001246360-12-004606
2012-09-04 Synageva Biopharma Corp
GEVA 		S, Open-market sale 54,813 disposed 49.36 2,705,372.35 Form 4, filing 0001246360-12-003697
2012-08-31 Synageva Biopharma Corp
GEVA 		S, Open-market sale 15,187 disposed 49.88 757,518.45 Form 4, filing 0001246360-12-003697
2012-06-04 Synageva Biopharma Corp
GEVA 		S, Open-market sale 20,866 disposed 34.69 723,785.20 Form 4, filing 0001246360-12-002671
2012-06-01 Synageva Biopharma Corp
GEVA 		S, Open-market sale 19,900 disposed 35.70 710,445.92 Form 4, filing 0001246360-12-002671
2012-06-01 Synageva Biopharma Corp
GEVA 		S, Open-market sale 9,234 disposed 35.96 332,086.96 Form 4, filing 0001246360-12-002671
2012-03-23 Synageva Biopharma Corp
GEVA 		S, Open-market sale 50,000 disposed 33.53 1,676,410.00 Form 4, filing 0001246360-12-001883

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 87
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Patel Sanj K, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001532218

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.